National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN and Lilly Quality of Care in Gastric Opportunity: Submit by October 24, 2018
ORP Recent News
ORP Affiliate Research Consortium
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

NCCN Oncology Research Program (ORP)

NCCN ORP Mission Statement

The NCCN ORP strives to improve the quality of life for patients and reduce cancer-related deaths by advancing cancer therapies through research. We believe we can achieve this goal by supporting oncology preclinical, translational, and clinical research at NCCN Member Institutions. We recognize the importance of developing and maintaining strong alliances with industry and actively facilitating collaborations between academia and industry drug developers making important scientific strides in the field of oncology. It is NCCN's vision to have the NCCN ORP become a Center for Excellence in the United States for providing outstanding research and research services.

Current Opportunities

NCCN and Lilly Quality of Care in Gastric Cancer Opportunity: Submit by October 24, 2018


The NCCN Oncology Research Program (ORP) is organized to obtain funding to support scientifically meritorious research studies (clinical trials) at NCCN Member Institutions. Policies and standards for the program are set by the NCCN Investigator Steering Committee, comprised of senior research physicians appointed by each NCCN Member Institution. The NCCN ORP has received millions of dollars in research grants from major pharmaceutical companies to support investigator-initiated trials, which explore new venues of clinical investigation that answer important research questions. Studies evaluate innovative combinations and sequencing regimens of drugs, mechanisms of action of specific agents, drug resistance, or are directed toward exploring extended uses for specific agents.

View the NCCN ORP Press Releases
View the NCCN ORP Scientific Publications
View the NCCN Investigator Steering Committee
View the NCCN ORP Testimonials
View the NCCN ORP Disclosure Policy

Leading clinicians and investigators from NCCN Member Institutions evaluate promising new chemical entities or biological agents.

Members Only Section

NCCN Oncology Research Program (ORP) – Click here if you are a clinician at an NCCN Member Institution and would like to:

  • Update your information in the Investigator Database
  • View current opportunities for research grants
  • View information regarding previously funded research grants

Industry Section

View information for the NCCN Oncology Research Program for Industry.